$0.505000
-0.02-2.92%
At close: -
$0.509900
0.00490.97%
After Hours: 9:29 AM EDT
Comments
Loading...
Cognition Therapeutics (NASDAQ:CGTX) Stock, Earnings Estimates, EPS, And Revenue
Cognition Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Nov 19
EPS Estimate
$-0.210
Quarterly Revenue Estimate
–
Annual Revenue
(as of Jun 30)
(as of Jun 30)
–
Analyze the earnings history of Cognition Therapeutics using advanced sorting and filters.
Data brought to you by Benzinga APIs
Cognition Therapeutics (CGTX) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Jun 2024 | 2024-08-08 | $-0.18 | $-0.23 | 21.7 % |
| Mar 2024 | 2024-05-07 | $-0.27 | $-0.29 | 6.90 % |
| Sep 2023 | 2023-11-02 | $-0.22 | $-0.24 | 8.33 % |
| Jun 2023 | 2023-08-08 | $-0.16 | $-0.19 | 15.8 % |
Cognition Therapeutics (CGTX) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
FAQ
When is Cognition Therapeutics (NASDAQ:CGTX) reporting earnings?
Cognition Therapeutics (CGTX) is scheduled to report earnings on November 19, 2024. The last reported earnings were for reported on August 8, 2024 for Q2.
What were the latest earnings per share (EPS) for Cognition Therapeutics (NASDAQ:CGTX)?
The Actual EPS was $-0.18, which beat the estimate of $-0.23.
What were Cognition Therapeutics’s (NASDAQ:CGTX) revenues?
The Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.